2BH Stock Overview
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
HCA Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$298.40 |
| 52 Week High | US$309.10 |
| 52 Week Low | US$206.70 |
| Beta | 1.67 |
| 1 Month Change | -1.39% |
| 3 Month Change | 14.46% |
| 1 Year Change | 16.43% |
| 3 Year Change | 80.47% |
| 5 Year Change | 171.32% |
| Change since IPO | 160.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2BH | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.9% | 5.4% | 1.7% |
| 1Y | 16.4% | 0.6% | 2.3% |
Price Volatility
| 2BH volatility | |
|---|---|
| 2BH Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Volatility Over Time: 2BH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 265,000 | Sam Hazen | www.hcahealthcare.com |
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.
HCA Healthcare, Inc. Fundamentals Summary
| 2BH fundamental statistics | |
|---|---|
| Market cap | €78.68b |
| Earnings (TTM) | €4.89b |
| Revenue (TTM) | €60.58b |
16.1x
P/E Ratio1.3x
P/S RatioIs 2BH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2BH income statement (TTM) | |
|---|---|
| Revenue | US$64.97b |
| Cost of Revenue | US$39.39b |
| Gross Profit | US$25.58b |
| Other Expenses | US$20.34b |
| Earnings | US$5.24b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 19.82 |
| Gross Margin | 39.37% |
| Net Profit Margin | 8.07% |
| Debt/Equity Ratio | 3,668.5% |
How did 2BH perform over the long term?
See historical performance and comparison